Navigation Links
PDL BioPharma to Present at the 25th Annual Piper Jaffray Healthcare Conference
Date:12/2/2013

INCLINE VILLAGE, Nev., Dec. 2, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, is scheduled to present at the 25th Annual Piper Jaffray Healthcare Conference in New York tomorrow, Tuesday, December 3, 2013 at 3:00 p.m. Eastern Time.

(Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)

This presentation will be available to interested parties through a live and archived audio webcast. To access the live and subsequently archived webcast of the presentation, go to the Company's website at http://www.pdl.com and go to "Events and Presentations." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary. The archived webcast will be available for seven days following the presentation.

About PDL BioPharma, Inc.
PDL BioPharma manages a portfolio of patents and royalty assets, consisting primarily of its Queen et al. antibody humanization patents and license agreements with various biotechnology and pharmaceutical companies. PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases for which it receives significant royalty revenue. PDL is currently focused on intellectual property asset management, investing in new income generating assets, and maximizing value for its shareholders.

The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL was founded in 1986 and is headquartered in Incline Vil
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. UCLA Venture Capital Fund Selects KYTHERA Biopharmaceuticals CEO Keith Leonard for First Annual Entrepreneurial Achievement Award
2. IPO, Earnings & Corporate Developments: Twitter, Vale SA, OCZ Technology Group, Radian Group, Keryx Biopharmaceuticals
3. TransCelerate BioPharma Inc. Launches Second Year Initiatives, Expands Membership and Achieves Milestones for Original Projects
4. Biopharmaceuticals - A Global Market Overview
5. Can-Fite BioPharma to Conduct European Road Show
6. MGB Biopharma to Present at Bio-Europe 2013
7. Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support
8. PDL BioPharma to Announce Third Quarter 2013 Financial Results on November 6, 2013
9. Regeneron Named Top Employer in the Global Biopharmaceutical Industry for the Second Year in a Row
10. Bright Future Ahead for Biopharmaceutical Contract Manufacturing, Says Frost & Sullivan
11. Enteris BioPharma and Nordic BioSciences KeyBioScience Enter Strategic Licensing Agreement to Develop Metabolic Peptides Using Enteris Proprietary Oral Drug Delivery and Manufacturing Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014  Neogen Corporation (Nasdaq: NEOG ... its potential revenue from new rodenticide research are premature. ... analysts on July 22, 2014, Neogen,s CEO commented about ... research. "It was my intent Tuesday at ... of a new type of rodenticide, but certainly not ...
(Date:7/24/2014)... The first part of the session ... in Human Studies” will cover comprehensive clinical support in ... With increasing R&D costs and declining industry success in ... the knowledge collected in early Phase I/IIa study data ... late stage development. , Next, the presenters will examine ...
(Date:7/24/2014)... , July 24, 2014   Cypher Genomics, ... the appointment of Adam Simpson as ... provides rapid and comprehensive annotation and interpretation of ... reporting. "Cypher,s technology has the potential ... by enhancing diagnostic accuracy, optimizing therapeutic approaches and ...
(Date:7/23/2014)... 24, 2014 Lyfebulb, the International Pemphigus ... and NASDAQ OMX First North Premier, ... announced a collaboration to increase awareness of unmet ... an event attended by more than sixty patients, ... a health and wellness company dedicated to serving ...
Breaking Biology Technology:Neogen comments on SenesTech 2Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 2Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 3Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 2Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 3Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 4Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 5
... 22, 2012 /PRNewswire-iReach/ -- FirstMark, the diagnostic ... that the company will be exhibiting at the 61st ... of Cardiology (ACC) in Chicago, March 24-27, Booth #15084. ... is the first and only multiple biomarker blood test ...
... The new Dynaflow Resolve System was developed in close ... demand for a simpler technology capable of complex perfusion ... perfusion system that enables novel experimental protocols by allowing ... type, and any compound. The new and improved system ...
... March 21, 2012 AtheroNova Inc. (OTCBB: AHRO), a ... compounds to regress atherosclerotic plaque, today announced that it ... development stage company, no revenues were recognized in the ... were $2,560,235 for 2011 compared to $2,679,435 in 2010. ...
Cached Biology Technology:FirstMark Exhibiting at the American College of Cardiology 61st Annual Scientific Sessions & Expo 2Cellectricon Launches Dynaflow® Resolve System Enabling Novel Ion Channel Assays 2AtheroNova Releases 2011 Financial Results 2AtheroNova Releases 2011 Financial Results 3
(Date:7/24/2014)... which life arose have been maintained in our cells today ... Research published today in the Journal of Biological Chemistry ... also in animals still perform ancient reactions thought to have ... billion years ago. , The primordial soup theory suggests that ... of the combination of metals, gases from the atmosphere and ...
(Date:7/24/2014)... . , Electric cars ... common sight on the roads of the Scandinavian country ... new vehicle registrations for the second time. This poses a ... claim only a small portion of the market. Of the ... mere 8000 are electric powered. The main factors discouraging motorists ...
(Date:7/23/2014)... SAN DIEGO , July 24, 2014 Pfenex ... initial public offering of 8,333,333 shares of its common stock ... In addition, Pfenex has granted the underwriters a 30-day option ... at the initial public offering price. The shares are expected ... 2014, under the symbol "PFNX". William Blair ...
Breaking Biology News(10 mins):Nano-supercapacitors for electric cars 2Nano-supercapacitors for electric cars 3Pfenex Inc. Announces Pricing Of Initial Public Offering 2
... cell biology and showing off the powers of new ... Golgi apparatus, which sorts newly synthesized proteins for transport ... during cell division, according to research to be presented ... Cell Biology (ASCB) annual meeting in New Orleans. ...
... the year,s end-of-life refrigerators, TVs, mobile phones, computers, monitors, ... cord worldwide could fill a line of 40-ton trucks ... Equator. That forecast, based on data compiled by ... of UN organizations, industry, governments, non-government and science organizations ...
... that present-day organisms evolved from earlier life forms. ... enzymes that help complete chemical processessuch as converting food ... Now a University of Iowa researcher and his colleagues ... "dihydrofolate reductase" as it occurred from bacteria to humans. ...
Cached Biology News:High-resolution 3-D imaging draws new picture of Golgi's whereabouts during cell division 2World e-waste map reveals national volumes, international flows 2World e-waste map reveals national volumes, international flows 3World e-waste map reveals national volumes, international flows 4World e-waste map reveals national volumes, international flows 5UI researcher studies evolution on the molecular level 2
... DNA Engine Dyad instrument is the most ... Featuring MJ's world-class thermal performance, the Dyad ... as well as point-and-click navigation via touch ... can be easily and economically expanded to ...
...
Practical tool for easy, effective sealing of 0.2ml PCR tubes and plates using cap strips....
... RT Telomerase Detection Kit is ... assay for the fluorometric detection ... telomerase activity. It incorporates refinements ... and adds the ability to ...
Biology Products: